Cargando…
Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?
Epigenetics is essentially a phenotypical change in gene expression without any alteration of the DNA sequence; the emergence of epigenetics in cancer research and mainstream oncology is fueling new hope. However, it is not yet known whether this knowledge will translate to improved clinical managem...
Autores principales: | Nguyen, Ha T., Tian, Geng, Murph, Mandi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986558/ https://www.ncbi.nlm.nih.gov/pubmed/24782983 http://dx.doi.org/10.3389/fonc.2014.00071 |
Ejemplares similares
-
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
por: Wang, Xin, et al.
Publicado: (2021) -
The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer
por: Cherifi, François, et al.
Publicado: (2022) -
MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019) -
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020) -
Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p
por: Nguyen, Ha T., et al.
Publicado: (2015)